Found 27 matching trials
CIML NK Cell in Head & Neck Cancer PHASE1 This research study is evaluating the safety and efficacy of a combination ...
Show More Location
Dana Farber Cancer Institute
Learn More & Join Trial
N-803 Combined With the Broadly Neutralizing Antibodies Plus or Minus haNK Cells for HIV PHASE1 To assess the safety of combination immune therapy in HIV-infected particip...
Show More Location
University of California
Learn More & Join Trial
Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Acute HIV Infection PHASE2 Reducing HIV persistence in lymph nodes by Interleukin-15 (IL-15) Receptor ...
Show More Status
Active Not Recruiting
Location
Thai Red Cross AIDS Research Centre
Learn More & Join Trial
A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer PHASE1 This is a Phase Ib/IIb, randomized, two-cohort, open-label, multicenter stu...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma PHASE2 This study consists of 2 portions. The phase 2 portion is an open-label, si...
Show More Status
Active Not Recruiting
Location
Chan Soon-Shiong Institute for Medicine (CSSIFM)
Learn More & Join Trial
A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer PHASE2 This is phase 2 single arm study evaluating the safety and preliminary effi...
Show More Location
Chan Soon-Shiong Institute for Medicine
Learn More & Join Trial
NAI for Sepsis With Persistent Lymphopenia PHASE2 This is a Phase 2, randomized, open-label study evaluating the safety and e...
Show More Location
Multiple Locations
Learn More & Join Trial
Nogapendekin Alfa-Inbakicept and iNKT Cells for Critically Ill Adults With Severe Community-Acquired Pneumonia (With or Without Sepsis/ARDS) PHASE2 This Phase 2 study tests whether adding two immune therapies - nogapendekin...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin Lymphoma PHASE2 Open-Label, Phase 2 Chemotherapy-Free Study ofCD19 t-haNK and NAI in Combin...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of Neutralizing Antibodies and Vaccination for Induction of HIV Remission PHASE1 This is a phase I, randomized, open-label trial to investigate the safety o...
Show More Location
Thai Red Cross AIDS Research Centre (TRCARC)
Learn More & Join Trial